101 related articles for article (PubMed ID: 10319950)
1. Tissue-specific differential repression of gene expression by a dominant negative mutant of thyroid hormone beta1 receptor.
Bhat MK; Dace A; Cheng SY
Thyroid; 1999 Apr; 9(4):411-8. PubMed ID: 10319950
[TBL] [Abstract][Full Text] [Related]
2. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
3. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
5. Identification of naturally occurring dominant negative mutants of thyroid hormone alpha 1 and beta 1 receptors in a human hepatocellular carcinoma cell line.
Lin KH; Zhu XG; Shieh HY; Hsu HC; Chen ST; McPhie P; Cheng SY
Endocrinology; 1996 Oct; 137(10):4073-81. PubMed ID: 8828459
[TBL] [Abstract][Full Text] [Related]
6. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
7. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
[TBL] [Abstract][Full Text] [Related]
8. Active repression by thyroid hormone receptor splicing variant alpha2 requires specific regulatory elements in the context of native triiodothyronine-regulated gene promoters.
Farsetti A; Lazar J; Phyillaier M; Lippoldt R; Pontecorvi A; Nikodem VM
Endocrinology; 1997 Nov; 138(11):4705-12. PubMed ID: 9348197
[TBL] [Abstract][Full Text] [Related]
9. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
[TBL] [Abstract][Full Text] [Related]
10. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
[TBL] [Abstract][Full Text] [Related]
11. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
Tagami T; Jameson JL
Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the thyroid hormone beta1 receptor increases basal and triiodothyronine-induced growth hormone messenger ribonucleic acid in GH3 cells.
Ball SG; Ikeda M; Chin WW
Endocrinology; 1997 Aug; 138(8):3125-32. PubMed ID: 9231759
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
14. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor.
Schaufele F; West BL; Baxter JD
Mol Endocrinol; 1992 Apr; 6(4):656-65. PubMed ID: 1584227
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
Zhu XG; McPhie P; Cheng SY
Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
Sakurai A; Miyamoto T; Refetoff S; DeGroot LJ
Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193
[TBL] [Abstract][Full Text] [Related]
19. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
Zavacki AM; Harney JW; Brent GA; Larsen PR
Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
